Bioflow-DAPT Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Coronary (Artery) Disease
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Prospective, multi-center, international, two-arm randomized controlled clinical study.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04137510
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Marco Valgimigli, Prof. Dr. Cardiocentro Ticino, Via Tesserete 48, 6900 Lugano, Switzerland